Article Details

Refining Adjuvant Immunotherapy Use is a Crucial Focus in Early-Stage NSCLC - OncLive

Retrieved on: 2024-08-03 07:17:00

Tags for this article:

Click the tags to see associated articles and topics

Refining Adjuvant Immunotherapy Use is a Crucial Focus in Early-Stage NSCLC - OncLive. View article details on hiswai:

Excerpt

Kaushal Parikh, MBBS, discusses treatment advances in early-stage NSCLC including for patients with actionable mutations, ...

Article found on: www.onclive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up